R&D | January 14, 2026
Codexis teams up with Axolabs to advance enzymatic RNA manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
The study showed a statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at Week 28 compared with placebo
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Subscribe To Our Newsletter & Stay Updated
